Human Food Safety of New Animal Drugs: Toxicology Assessment
Regulating Animal Drugs
description
Transcript of Regulating Animal Drugs
![Page 1: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/1.jpg)
Mrs. Brandi RobinsonOffice of New Animal Drug Evaluation
Center for Veterinary Medicine
Regulating Animal Drugs
![Page 2: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/2.jpg)
• Protect the Public Health by ensuring • safe and effective animal drugs
reach the market•unsafe and ineffective animal
drugs do not reach the market
Regulating Animal Drugs
![Page 3: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/3.jpg)
Animal drugs are articles intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in animals and articles intended to affect the structure or any function of the body of the animal
Defining Animal Drugs
![Page 4: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/4.jpg)
• The product is safe and effective for its intended use.
• The methods, facilities and controls used for the manufacturing, processing and packaging of the drug are adequate to preserve its identity, strength, quality and purity.
Approved Animal Drug
![Page 5: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/5.jpg)
• Human Food Safety
• Toxicology• Residue Chemistry• Microbial Food Safety
• Target Animal Safety• Effectiveness • Manufacturing Chemistry • Environmental Impact• Labeling• All Other Information
Areas of Review
![Page 6: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/6.jpg)
• Example: Based on substantial evidence consisting of one or more adequate and well-controlled investigations such as –
• a study in a target species• a study in laboratory animals• any field investigation• a bioequivalence study• an in vitro study
Defining Effectiveness
![Page 7: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/7.jpg)
• Example: Adequate tests by all methods reasonably applicable show that the drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling.
Defining Safety
![Page 8: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/8.jpg)
Safety may include:• Target Animal Safety• Human Food Safety• Environmental Impact• User Safety
Safety
![Page 9: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/9.jpg)
• The cumulative effect of the drug on the animal(s), such that the drug does not adversely affect the treated animal(s)
Target Animal Safety
![Page 10: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/10.jpg)
• Toxicology
• Residue Chemistry
• Microbial Food Safety
• Regulatory Method
Human Food Safety
![Page 11: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/11.jpg)
• Use, manufacture and disposal does not pose a significant environmental impact
Environmental Impact
![Page 12: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/12.jpg)
• Hazards associated with administration to animals
• Hazards associated with manufacturing • Direct - occupational exposure at
site• Indirect - manufacturing emissions
• Hazards associated with use of air, water and solid wastes contaminated via use and disposal of the drug
User Safety
![Page 13: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/13.jpg)
Determines whether an animal drug will have and maintain the necessary quality, strength, purity, and identity• Methods and controls• Stability data• GMP compliance
Manufacturing Chemistry
![Page 14: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/14.jpg)
• Immediate container (vial, syringe, packet) or feed bag labels
• Package insert• Packaging (box, carton)
Labeling
![Page 15: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/15.jpg)
• Foreign marketing experience• Reports of pilot studies• Literature reports
All Other Information
![Page 16: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/16.jpg)
• Pre-submission conference - formal process• Sponsor and CVM may discuss and voluntarily
agree on
• Product Development Plan• General design for each study or use of a
standard protocol
• CVM provides guidance documents for various studies
• Simultaneous work under each area of review
Example Approval Process:The United States Approach
![Page 17: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/17.jpg)
• Sponsor conducts studies to generate data following protocol concurrence
• Data is evaluated by sponsor and CVM for quality assurance (data integrity)
• Data is scientifically reviewed by CVM
• CVM determines if study is acceptable (pivotal) for making safety or effectiveness decision
Example Approval Process:The United States Approach
![Page 18: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/18.jpg)
• NADA is a systematic approach to document evidence that drug products are safe and effective
• Approved drug product consists of the drug, the packaging and the labeling
Example Approval Process:The United States Approach
![Page 19: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/19.jpg)
• CVM describes the documented evidence in a Freedom of Information Summary, an Environmental Assessment, and in drug labeling.
• Codifies the approval in the CFR via a Federal Register announcement.
• All are accessible by the public
Example Approval Process:The United States Approach
![Page 20: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/20.jpg)
• Protect the Public Health by ensuring • safe and effective new animal
drugs reach the market•unsafe and ineffective new animal
drugs do not reach the market• Work efficiently to process and
review sponsor submissions and applications
• Work within the limits of statutory authority
Example Approval Process:The United States Approach
![Page 21: Regulating Animal Drugs](https://reader035.fdocuments.net/reader035/viewer/2022062410/56816047550346895dcf6c29/html5/thumbnails/21.jpg)
Thank you!
Additional Videos on Animal Drug
Regulation Available